JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB115569

Anti-TFEC antibody

Be the first to review this product! Submit a review

|

(2 Publications)

Goat Polyclonal TFEC antibody. Suitable for IHC-P and reacts with Human samples. Cited in 2 publications. Immunogen corresponding to Synthetic Peptide within Mouse Tfec aa 200-250.

View Alternative Names

BHLHE34, TCFEC, TFECL, TFEC, Transcription factor EC, TFE-C, Class E basic helix-loop-helix protein 34, Transcription factor EC-like, bHLHe34, hTFEC-L

2 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-TFEC antibody (AB115569)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-TFEC antibody (AB115569)

Human spleen (formalin-fixed, paraffin-embedded) stained with ab115569 at 5 μg/ml followed by biotinylated anti-goat IgG secondary antibody, alkaline phosphatase-streptavidin and chromogen.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-TFEC antibody (AB115569)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-TFEC antibody (AB115569)

Human kidney (formalin-fixed, paraffin-embedded) stained with ab115569 at 5 μg/ml followed by biotinylated anti-goat IgG secondary antibody, alkaline phosphatase-streptavidin and chromogen.

Key facts

Host species

Goat

Clonality

Polyclonal

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

IHC-P

applications

Immunogen

Synthetic Peptide within Mouse Tfec aa 200-250. The exact immunogen used to generate this antibody is proprietary information.

Q9WTW4

style
left-column

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "5 µg/mL", "IHCP-species-notes": "<p></p> Perform heat-mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol." } } }
style
left-column
style
left-column

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Immunogen
Storage buffer
pH: 7.3 Preservative: 0.02% Sodium azide Constituents: 99% Tris buffered saline, 0.5% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
style
left-column
style
left-column
style
left-column

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:
style
left-column

Target data

Transcriptional regulator that acts as a repressor or an activator. Acts as a transcriptional repressor on minimal promoter containing element F (that includes an E-box sequence). Binds to element F in an E-box sequence-specific manner. Acts as a transcriptional transactivator on the proximal promoter region of the tartrate-resistant acid phosphatase (TRAP) E-box containing promoter (By similarity). Collaborates with MITF in target gene activation (By similarity). Acts as a transcriptional repressor on minimal promoter containing mu E3 enhancer sequence (By similarity). Binds to mu E3 DNA sequence of the immunoglobulin heavy-chain gene enhancer (By similarity). Binds DNA in a homo- or heterodimeric form.
See full target information TFEC
style
left-column

Publications (2)

Recent publications for all applications. Explore the full list and refine your search

Histopathology 72:786-794 PubMed29148086

2018

Novel gene fusion of PRCC-MITF defines a new member of MiT family translocation renal cell carcinoma: clinicopathological analysis and detection of the gene fusion by RNA sequencing and FISH.

Applications

Unspecified application

Species

Unspecified reactive species

Qiu-Yuan Xia,Xiao-Tong Wang,Sheng-Bing Ye,Xuan Wang,Rui Li,Shan-Shan Shi,Ru Fang,Ru-Song Zhang,Heng-Hui Ma,Zhen-Feng Lu,Qin Shen,Wei Bao,Xiao-Jun Zhou,Qiu Rao

Oncotarget 7:37846-37856 PubMed27191985

2016

Gene-expression analysis of gleason grade 3 tumor glands embedded in low- and high-risk prostate cancer.

Applications

Unspecified application

Species

Unspecified reactive species

A Marije Hoogland,René Böttcher,Esther Verhoef,Guido Jenster,Geert J L H van Leenders
View all publications
style
left-column
style
left-column
style
right-column

Complementary Products

Primary Antibodies

AB247808

Anti-SLP76 antibody [EPR2549(2)] - BSA and Azide free

RabMAb|Recombinant

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-SLP76 antibody [EPR2549(2)] - BSA and Azide free (AB247808)

  • 0
  • 0
Primary Antibodies

AB290680

Anti-DAP12 antibody [EPR5173-40] - BSA and Azide free (Capture)

RabMAb|Recombinant

Sandwich ELISA - Anti-DAP12 antibody [EPR5173-40] - BSA and Azide free (Capture) (AB290680)

  • 0
  • 0
Primary Antibodies

AB150584

Anti-GPCR GPR14 antibody - N-terminal

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-GPCR GPR14 antibody - N-terminal (AB150584)

  • 0
  • 0
Primary Antibodies

AB109497

Anti-PBR antibody [EPR5384]

RabMAb|Recombinant|KO Validated|20ul selling size

Immunocytochemistry/ Immunofluorescence - Anti-PBR antibody [EPR5384] (AB109497)

  • 5
  • 15

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com